Related Experiment Videos
Hypophosphatemia in hypercatabolic patients.
Acta Anaesthesiologica Scandinavica. Supplementum
|January 1, 1985
Summary
This study found that a daily phosphate dose of 0.5 mmol/kg effectively prevents hypophosphatemia in surgical intensive care patients receiving total parenteral nutrition (TPN). This phosphate regimen is adequate for managing increased nutrient needs in these critical patients.
Area of Science:
- Critical Care Medicine
- Nutritional Support
- Surgical Patient Management
Background:
- Hypercatabolic surgical patients receiving total parenteral nutrition (TPN) are at risk of hypophosphatemia.
- Hypophosphatemia can lead to severe complications in critically ill patients.
- Accurate phosphate management is crucial during TPN in surgical intensive care units.
Purpose of the Study:
- To evaluate the adequacy of a daily phosphate dosage of 0.5 mmol/kg body weight.
- To assess the impact of this phosphate regimen on plasma phosphate levels in surgical ICU patients on TPN.
- To determine if this dosage prevents hypophosphatemia in hypercatabolic surgical patients.
Main Methods:
- Twenty-four hypercatabolic surgical intensive care patients were enrolled.
- Patients received a daily phosphate dosage of 0.5 mmol/kg body weight during TPN.
- Plasma phosphate concentrations were measured before and after five days of TPN.
Main Results:
- Ten patients were initially hypophosphatemic; none were hypophosphatemic after five days of TPN.
- All patients remained in negative nitrogen balance throughout the study.
- One instance of hyperphosphatemia was noted at the study's conclusion.
Conclusions:
- A daily phosphate dosage of 0.5 mmol/kg is adequate for surgical intensive care patients on TPN.
- This phosphate regimen effectively prevents hypophosphatemia in this patient population.
- Catabolic surgical patients on parenteral nutrition require careful phosphate monitoring and supplementation.